Beta Thalassemia: FDA Approves Second Crispr Treatment for an Inherited Blood Disorder
The gene therapy developed by Vertex Pharmaceuticals and CRISPR Therapeutics for the treatment of beta thalassemia, requiring regular blood…
Read More...
Read More...